GSK - Ticker AI Digest

GlaxoSmithKline PLC 📰 2
1950.00 | Today -1.14%

Digested News

All RNS Today (GSK) 2
GSK 11:01
GlaxoSmithKline PLC
Lynavoy (linerixibat) approved by US FDA
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
AI 0
No items for this category on selected date.
Acquisitions 1
Agreement 1
GSK 06:01
GlaxoSmithKline PLC
GSK enters agreement to acquire 35Pharma
Approvals 2
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 1
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 12
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 15:55
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 1
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 2
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All RNS (Last 30 Days) 47
GSK 11:01
GlaxoSmithKline PLC
Lynavoy (linerixibat) approved by US FDA
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:01
GlaxoSmithKline PLC
Board Committee Change
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 09:01
GlaxoSmithKline PLC
GSK publishes Annual Report 2025
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:01
GlaxoSmithKline PLC
Total Voting Rights
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 15:55
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
GSK enters agreement to acquire 35Pharma
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 06:01
GlaxoSmithKline PLC
Transaction in Own Shares
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding
GSK 14:31
GlaxoSmithKline PLC
Director/PDMR Shareholding

AI Crunch

Single-Ticker AI Crunch
GSK signal theatre built from scored RNS, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for GlaxoSmithKline PLC. It compresses bullish and bearish RNS scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Subscriber Unlock
Subscribe to unlock the full GSK AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored RNS row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Upcoming earnings radar so catalysts sit next to the news flow.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for GSK on 2026-03-19.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
78992949248
Enterprise Value
70042705076
Public Float
96.71
Broker Target
2032.25
Shares Out
4003922104
Long Interest
96
Short Interest
4
Exchange
LSE
Currency Code
GBX
ISIN
GB00BN7SWP63
Market
LSE - MAIN MARKET
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.72
Ex Divi
2026-02-19
Earnings Date
2026-02-03
Net Debt
14323000000.0
Cash
3397000000.0
EPS
1.39
Net Income
5716000000.0
Revenue
32667000000.0
Enterprise Value
70042705076
Trailing PE
14.1906
Forward PE
21.097
Price Sales TTM
2.4181
Price Book MRQ
4.9215
EV Revenue
2.913
EV EBITDA
9.1482

Capital Radar

Capital Regime
Loading
Building signal blend...
Smart Money Tilt
Loading
Public vs institutions
Target Conviction
Loading
Broker coverage pulse
Insider Pressure
Loading
Director + TR1 flow
Last Held Position
4003922104
Public Hands
96.71
Institutions
-
Institutions As Of
-
Avg Broker Target
1742.3684
Upside Vs Price
-10.65%
Purchase Director Dealing
11
Sale Director Dealing
18
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
38
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

GSK Price History Last 30 Days
Chart Intelligence Suite
Turn every chart into a live signal desk built to surface conviction in seconds.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and RNS beacons pin market-moving disclosures directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD RNS Beacons Live Price Structure
Indicators
Technicals
AI Forecast 25.48%
RSI Gauge
Price Change
AI Forecast
Loading